Behind the Science: Reprogramming Resistance to Prostate Cancer Treatment
Prostate cancer is one of the most common – and most lethal – cancers in men. In the United States alone, nearly 300,000 new cases are diagnosed each year, and it remains the second-leading cause of cancer death among men.
Behind the Science: Reprogramming Resistance to Prostate Cancer Treatment
Prostate cancer is one of the most common – and most lethal – cancers in men. In the United States alone, nearly 300,000 new cases are diagnosed each year, and it remains the second-leading cause of cancer death among men.
Inside Pfizer’s Fight Against Counterfeit Medicine
The U.S. and Canada combined accounted for more than 2,000 incidents involving counterfeit, diverted, and stolen medicines last year, according to the Pharmaceutical Security Institute (PSI).
Inside Pfizer’s Fight Against Counterfeit Medicine
The U.S. and Canada combined accounted for more than 2,000 incidents involving counterfeit, diverted, and stolen medicines last year, according to the Pharmaceutical Security Institute (PSI).
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
The Hidden Infrastructure Behind Every Pfizer Medicine
Getting a medication can seem as simple as a trip to the pharmacy. In reality, that moment is the last step in a complex, rigorous, and largely invisible process.
The Hidden Infrastructure Behind Every Pfizer Medicine
Getting a medication can seem as simple as a trip to the pharmacy. In reality, that moment is the last step in a complex, rigorous, and largely invisible process.
Behind the Science: Reprogramming Resistance to Prostate Cancer Treatment
Prostate cancer is one of the most common – and most lethal – cancers in men. In the United States alone, nearly 300,000 new cases are diagnosed each year, and it remains the second-leading cause of cancer death among men.
Behind the Science: Reprogramming Resistance to Prostate Cancer Treatment
Prostate cancer is one of the most common – and most lethal – cancers in men. In the United States alone, nearly 300,000 new cases are diagnosed each year, and it remains the second-leading cause of cancer death among men.
Inside Pfizer’s Fight Against Counterfeit Medicine
The U.S. and Canada combined accounted for more than 2,000 incidents involving counterfeit, diverted, and stolen medicines last year, according to the Pharmaceutical Security Institute (PSI).
Inside Pfizer’s Fight Against Counterfeit Medicine
The U.S. and Canada combined accounted for more than 2,000 incidents involving counterfeit, diverted, and stolen medicines last year, according to the Pharmaceutical Security Institute (PSI).
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
A Return to Munich: Reflecting on Eight Years of Progress in ATTR-CM
Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.
The Hidden Infrastructure Behind Every Pfizer Medicine
Getting a medication can seem as simple as a trip to the pharmacy. In reality, that moment is the last step in a complex, rigorous, and largely invisible process.
The Hidden Infrastructure Behind Every Pfizer Medicine
Getting a medication can seem as simple as a trip to the pharmacy. In reality, that moment is the last step in a complex, rigorous, and largely invisible process.